MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
22 10 2021
Historique:
accepted: 14 06 2021
received: 19 12 2020
revised: 08 06 2021
pubmed: 29 9 2021
medline: 15 12 2021
entrez: 28 9 2021
Statut: ppublish

Résumé

Striated muscle needs to maintain cellular homeostasis in adaptation to increases in physiological and metabolic demands. Failure to do so can result in rhabdomyolysis. The identification of novel genetic conditions associated with rhabdomyolysis helps to shed light on hitherto unrecognized homeostatic mechanisms. Here we report seven individuals in six families from different ethnic backgrounds with biallelic variants in MLIP, which encodes the muscular lamin A/C-interacting protein, MLIP. Patients presented with a consistent phenotype characterized by mild muscle weakness, exercise-induced muscle pain, variable susceptibility to episodes of rhabdomyolysis, and persistent basal elevated serum creatine kinase levels. The biallelic truncating variants were predicted to result in disruption of the nuclear localizing signal of MLIP. Additionally, reduced overall RNA expression levels of the predominant MLIP isoform were observed in patients' skeletal muscle. Collectively, our data increase the understanding of the genetic landscape of rhabdomyolysis to now include MLIP as a novel disease gene in humans and solidifies MLIP's role in normal and diseased skeletal muscle homeostasis.

Identifiants

pubmed: 34581780
pii: 6377325
doi: 10.1093/brain/awab275
pmc: PMC8536936
doi:

Substances chimiques

Co-Repressor Proteins 0
MLIP protein, mouse 0
Nuclear Proteins 0
Creatine Kinase EC 2.7.3.2

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2722-2731

Subventions

Organisme : CIHR
ID : MOP119470
Pays : Canada

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published by Oxford University Press on behalf of the Guarantors of Brain 2021.

Références

Neuromuscul Disord. 2013 Feb;23(2):116-9
pubmed: 23177318
J Neurol. 2020 Apr;267(4):877-882
pubmed: 30617905
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19254-19265
pubmed: 32719146
Neuropediatrics. 1998 Apr;29(2):97-101
pubmed: 9638664
Cells. 2021 Mar 10;10(3):
pubmed: 33802236
Pract Neurol. 2018 Feb;18(1):14-26
pubmed: 29223996
Pediatr Nephrol. 2017 Dec;32(12):2273-2282
pubmed: 28779239
J Biol Chem. 2011 Jun 3;286(22):19702-13
pubmed: 21498514
PLoS One. 2017 Mar 15;12(3):e0172995
pubmed: 28296976
Am J Hum Genet. 2016 Feb 4;98(2):358-62
pubmed: 26805782
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
Can J Neurol Sci. 2018 May;45(3):262-268
pubmed: 29382405
J Biol Chem. 2018 Dec 21;293(51):19761-19770
pubmed: 30389785
J Clin Invest. 2015 Nov 2;125(11):4122-34
pubmed: 26436652
Orphanet J Rare Dis. 2015 May 02;10:51
pubmed: 25929793
J Biol Chem. 2015 Oct 30;290(44):26699-714
pubmed: 26359501

Auteurs

Osorio Lopes Abath Neto (O)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Department of Pathology, Division of Neuropathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Livija Medne (L)

Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Sandra Donkervoort (S)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Maria Elena Rodríguez-García (ME)

Grupo de Enfermedades Raras, Mitocondriales y Neuromusculares (ERMN), Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Véronique Bolduc (V)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Ying Hu (Y)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Eleonora Guadagnin (E)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

A Reghan Foley (AR)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

John F Brandsema (JF)

Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Allan M Glanzman (AM)

Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Gihan I Tennekoon (GI)

Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Mariarita Santi (M)

Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Justin H Berger (JH)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Lynn A Megeney (LA)

Ottawa Hospital Research Institute, Ottawa ON, Canada.

Hirofumi Komaki (H)

National Center of Neurology and Psychiatry, Tokyo, Japan.

Michio Inoue (M)

National Center of Neurology and Psychiatry, Tokyo, Japan.

Francisco Javier Cotrina-Vinagre (FJ)

Grupo de Enfermedades Raras, Mitocondriales y Neuromusculares (ERMN), Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.

Aurelio Hernández-Lain (A)

Servicio de Anatomía Patológica (Neuropatología), Hospital 12 de Octubre, Madrid, Spain.

Elena Martin-Hernández (E)

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Unidad Pediátrica de Enfermedades Raras, Enfermedades Mitocondriales y Metabólicas Hereditarias, Hospital 12 de Octubre, Madrid, Spain.

Linford Williams (L)

Division of Medical Genetics, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

Sabine Borell (S)

Department of Neuropediatrics and Muscle Disorders, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

David Schorling (D)

Department of Neuropediatrics and Muscle Disorders, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Kimberly Lin (K)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Konstantinos Kolokotronis (K)

Institute of Human Genetics, Biocenter, Julius-Maximilians-University Würzburg, Würzburg, Germany.

Uta Lichter-Konecki (U)

Division of Medical Genetics, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

Janbernd Kirschner (J)

Department of Neuropediatrics and Muscle Disorders, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Department of Neuropediatrics, University Hospital Bonn, Faculty of Medicine, Bonn, Germany.

Ichizo Nishino (I)

National Center of Neurology and Psychiatry, Tokyo, Japan.

Brenda Banwell (B)

Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Francisco Martínez-Azorín (F)

Grupo de Enfermedades Raras, Mitocondriales y Neuromusculares (ERMN), Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Patrick G Burgon (PG)

Department of Chemistry and Earth Science, College of Arts and Sciences, Qatar University, Qatar.

Carsten G Bönnemann (CG)

Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH